Literature DB >> 14671979

Comparison of proliferation indices in glioblastoma multiforme by whole tissue section vs tissue microarray.

Andres G Chiesa-Vottero1, Lisa A Rybicki, Richard A Prayson.   

Abstract

Tissue microarrays (TMAs) reduce the amount of tissue analyzed with the assumption that protein and gene expression patterns are homogeneous throughout tumors. Many tumor types, including glioblastoma multiforme (GBM), are heterogeneous in many regards, including cell proliferation. We retrospectively compared Ki-67 labeling indices (LIs) determined by whole tissue section (WTS) vs TMA in a series of 50 GBMs from 45 patients. A paired t test indicated that the difference between average LIs obtained from a TMA vs a WTS was not significant (P = .51). There was no correlation between TMA and WTS (r = 0.042; P = .77), indicating that the methods yielded very different results in individual tumors. The Ki-67 LI did not always correlate with the tissue section in an individual tumor; however, when evaluating a large number of tumors on a TMA, the LI range and mean LI were roughly comparable with the LI range and mean LI determined from the WTS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14671979     DOI: 10.1309/8UAU-KFK3-NBDM-VTNU

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

1.  Clinical value of CD133 and nestin in patients with glioma: a population-based study.

Authors:  Rikke H Dahlrot; Steinbjørn Hansen; Stine S Jensen; Henrik D Schrøder; Jacob Hjelmborg; Bjarne W Kristensen
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  Histology-based expression profiling yields novel prognostic markers in human glioblastoma.

Authors:  Shumin Dong; Catherine L Nutt; Rebecca A Betensky; Anat O Stemmer-Rachamimov; Nicholas C Denko; Keith L Ligon; David H Rowitch; David N Louis
Journal:  J Neuropathol Exp Neurol       Date:  2005-11       Impact factor: 3.685

3.  Mitigating temozolomide resistance in glioblastoma via DNA damage-repair inhibition.

Authors:  Inmaculada C Sorribes; Samuel K Handelman; Harsh V Jain
Journal:  J R Soc Interface       Date:  2020-01-22       Impact factor: 4.118

4.  Concurrent Chemotherapy of Malignant Glioma in Rats by Using Multidrug-Loaded Biodegradable Nanofibrous Membranes.

Authors:  Yuan-Yun Tseng; Yin-Chen Huang; Tao-Chieh Yang; Shun-Tai Yang; Shou-Cheng Liu; Tzu-Min Chang; Yi-Chuan Kau; Shih-Jung Liu
Journal:  Sci Rep       Date:  2016-07-29       Impact factor: 4.379

5.  Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness.

Authors:  Alexandra Bogeas; Ghislaine Morvan-Dubois; Elias A El-Habr; François-Xavier Lejeune; Matthieu Defrance; Ashwin Narayanan; Klaudia Kuranda; Fanny Burel-Vandenbos; Salwa Sayd; Virgile Delaunay; Luiz G Dubois; Hugues Parrinello; Stéphanie Rialle; Sylvie Fabrega; Ahmed Idbaih; Jacques Haiech; Ivan Bièche; Thierry Virolle; Michele Goodhardt; Hervé Chneiweiss; Marie-Pierre Junier
Journal:  Acta Neuropathol       Date:  2017-11-17       Impact factor: 17.088

6.  APNG as a prognostic marker in patients with glioblastoma.

Authors:  Sigurd Fosmark; Sofie Hellwege; Rikke H Dahlrot; Kristian L Jensen; Helene Derand; Jesper Lohse; Mia D Sørensen; Steinbjørn Hansen; Bjarne W Kristensen
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

7.  A driver role for GABA metabolism in controlling stem and proliferative cell state through GHB production in glioma.

Authors:  Elias A El-Habr; Luiz G Dubois; Fanny Burel-Vandenbos; Alexandra Bogeas; Joanna Lipecka; Laurent Turchi; François-Xavier Lejeune; Paulo Lucas Cerqueira Coehlo; Tomohiro Yamaki; Bryan M Wittmann; Mohamed Fareh; Emna Mahfoudhi; Maxime Janin; Ashwin Narayanan; Ghislaine Morvan-Dubois; Charlotte Schmitt; Maité Verreault; Lisa Oliver; Ariane Sharif; Johan Pallud; Bertrand Devaux; Stéphanie Puget; Penelope Korkolopoulou; Pascale Varlet; Chris Ottolenghi; Isabelle Plo; Vivaldo Moura-Neto; Thierry Virolle; Hervé Chneiweiss; Marie-Pierre Junier
Journal:  Acta Neuropathol       Date:  2016-12-28       Impact factor: 17.088

8.  Capture at the single cell level of metabolic modules distinguishing aggressive and indolent glioblastoma cells.

Authors:  Mirca S Saurty-Seerunghen; Léa Bellenger; Elias A El-Habr; Virgile Delaunay; Delphine Garnier; Hervé Chneiweiss; Christophe Antoniewski; Ghislaine Morvan-Dubois; Marie-Pierre Junier
Journal:  Acta Neuropathol Commun       Date:  2019-10-16       Impact factor: 7.801

9.  Enhancing Brain Retention of a KIF11 Inhibitor Significantly Improves its Efficacy in a Mouse Model of Glioblastoma.

Authors:  Gautham Gampa; Rajappa S Kenchappa; Afroz S Mohammad; Karen E Parrish; Minjee Kim; James F Crish; Amanda Luu; Rita West; Alfredo Quinones Hinojosa; Jann N Sarkaria; Steven S Rosenfeld; William F Elmquist
Journal:  Sci Rep       Date:  2020-04-16       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.